Literature DB >> 8104513

Immunopathogenesis of human immunodeficiency virus infection.

G Poli1, G Pantaleo, A S Fauci.   

Abstract

Infection with human immunodeficiency virus (HIV) causes AIDS. As a consequence of the interaction of gp120 envelope with the CD4 receptor molecule expressed by a subset of T lymphocytes and by mononuclear phagocytes (MPs), a second envelope protein (gp41) mediates fusion of the virion membrane with the target membrane. In these events the role of adhesion molecules such as LFA-1 has recently been highlighted. Following viral entry, reverse transcription of the virion-associated RNA and integration of proviral DNA into the host genome are crucial steps in HIV infection, which can lead to expression of high levels of new HIV or to silent infection for indefinite periods, a condition defined as viral latency. Several factors in addition to endogenous viral regulatory proteins have been reported as capable of modulating the state of viral latency and expression in vitro, including the cytokine network that normally modulates immune homeostasis as well as the immune response to inflammatory stimuli. Finally, recent studies have underscored the observation that the CD4+ T lymphocytes are the major reservoir of HIV in the peripheral blood compartment and in the lymphoid tissues, which are characterized by a greater viral burden, whereas in nonlymphoid organs such as the brain and the lung, local infection is predominantly sustained by MPs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104513

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Fugetaxis: active movement of leukocytes away from a chemokinetic agent.

Authors:  Fabrizio Vianello; Ivona T Olszak; Mark C Poznansky
Journal:  J Mol Med (Berl)       Date:  2005-09-03       Impact factor: 4.599

2.  CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts.

Authors:  Stephen T Wright; Andrew Carr; Ian Woolley; Michelle Giles; Jennifer Hoy; David A Cooper; Matthew G Law
Journal:  J Acquir Immune Defic Syndr       Date:  2011-09-01       Impact factor: 3.731

Review 3.  Cell adhesion molecules in the pathogenesis of and host defence against microbial infection.

Authors:  J R Kerr
Journal:  Mol Pathol       Date:  1999-08

4.  Granulocyte macrophage colony stimulating factor is elevated in alveolar macrophages from sheep naturally infected with maedi-visna virus and stimulates maedi-visna virus replication in macrophages in vitro.

Authors:  Z Zhang; G D Harkiss; J Hopkins; C J Woodall
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

5.  Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.

Authors:  Stephen T Wright; Jennifer Hoy; Brian Mulhall; Catherine C Oʼconnor; Kathy Petoumenos; Timothy Read; Don Smith; Ian Woolley; Mark A Boyd
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

6.  Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120.

Authors:  Diana M Brainard; William G Tharp; Elva Granado; Nicholas Miller; Alicja K Trocha; Xiang-Hui Ren; Brian Conrad; Ernest F Terwilliger; Richard Wyatt; Bruce D Walker; Mark C Poznansky
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.

Authors:  Nitya Nair; William J Moss; Susana Scott; Nanthalile Mugala; Zaza M Ndhlovu; Kareem Lilo; Judith J Ryon; Mwaka Monze; Thomas C Quinn; Simon Cousens; Felicity Cutts; Diane E Griffin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

8.  The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.

Authors:  Liljana Stevceva; Victor Yoon; Angela Carville; Beatriz Pacheco; Michael Santosuosso; Birgit Korioth-Schmitz; Keith Mansfield; Mark C Poznansky
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

Review 9.  [Status and current strategies of HIV vaccine development].

Authors:  J Wild; R Wagner
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.834

10.  Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia.

Authors:  Stephen T Wright; Matthew G Law; David A Cooper; Phillip Keen; Ann McDonald; Melanie Middleton; Ian Woolley; Mark Kelly; Kathy Petoumenos
Journal:  J Int AIDS Soc       Date:  2015-04-10       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.